SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christopher Downing, Jonathan Moayyad, Aparna Tamirisa, Stephen Tyring, Acyclovir Lauriad®: a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis, Expert Review of Anti-infective Therapy, 2014, 12, 3, 283

    CrossRef

  2. 2
    Steven J. Coats, Ethel C. Garnier-Amblard, Franck Amblard, Maryam Ehteshami, Sheida Amiralaei, Hongwang Zhang, Longhu Zhou, Sebastien R.L. Boucle, Xiao Lu, Lavanya Bondada, Jadd R. Shelton, Hao Li, Peng Liu, Chengwei Li, Jong Hyun Cho, Satish N. Chavre, Shaoman Zhou, Judy Mathew, Raymond F. Schinazi, Chutes and ladders in hepatitis C nucleoside drug development, Antiviral Research, 2014, 102, 119

    CrossRef

  3. 3
    Subhajit Biswas, Soumi Sukla, Hugh J Field, Helicase–primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections, Future Medicinal Chemistry, 2014, 6, 1, 45

    CrossRef

  4. 4
    Hariharasudhan D. Chirra, Ling Shao, Natalie Ciaccio, Cade B. Fox, Jennifer M. Wade, Averil Ma, Tejal A. Desai, Planar Microdevices for Enhanced In Vivo Retention and Oral Bioavailability of Poorly Permeable Drugs, Advanced Healthcare Materials, 2014, 3, 4
  5. 5
    Xianzhi Peng, Chunwei Wang, Kun Zhang, Zhifang Wang, Qiuxin Huang, Yiyi Yu, Weihui Ou, Profile and behavior of antiviral drugs in aquatic environments of the Pearl River Delta, China, Science of The Total Environment, 2014, 466-467, 755

    CrossRef

  6. 6
    Qian Zhang, Yong-Zhen Huang, Jun-Hui Yang, Bai-Wei Ma, Gui-Rong Qu, Hai-Ming Guo, Synthesis of 9-oxiranyl-9H-purine derivatives in β-cyclodextrin cavity, Tetrahedron Letters, 2014, 55, 6, 1203

    CrossRef

  7. 7
    Marcin Chrusciel, Milena Doroszko, Joanna Stelmaszewska, Xiangdong Li, Adam J. Ziecik, Herjan J.T. Coelingh-Bennink, Ilpo Huhtaniemi, Nafis A. Rahman, Transgenic mice expressing inhibin α-subunit promoter (inhα)/Simian Virus 40 T-antigen (Tag) transgene as a model for the therapy of granulosa cell-derived ovarian cancer, Reproductive Biology, 2014, 14, 1, 25

    CrossRef

  8. 8
    Dilani D. Silva, Sylvie Rapior, Enge Sudarman, Marc Stadler, Jianchu Xu, S. Aisyah Alias, Kevin D. Hyde, Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry, Fungal Diversity, 2013, 62, 1, 1

    CrossRef

  9. 9
    Erik De Clercq, Dancing with chemical formulae of antivirals: A personal account, Biochemical Pharmacology, 2013, 86, 6, 711

    CrossRef

  10. 10
    F. G. Skiada, V. I. Maliogka, N. I. Katis, E. P. Eleftheriou, Elimination of Grapevine rupestris stem pitting-associated virus (GRSPaV) from two Vitis vinifera cultivars by in vitro chemotherapy, European Journal of Plant Pathology, 2013, 135, 2, 407

    CrossRef

  11. 11
    Anroop B. Nair, Mahesh Attimarad, Bandar E. Al-Dhubiab, Jyoti Wadhwa, Sree Harsha, Mueen Ahmed, Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin, Drug Delivery, 2013, 1

    CrossRef

  12. 12
    Wen-Li Gao, Ning Li, Min-Hua Zong, Enzymatic regioselective acylation of nucleosides in biomass-derived 2-methyltetrahydrofuran: Kinetic study and enzyme substrate recognition, Journal of Biotechnology, 2013, 164, 1, 91

    CrossRef

  13. 13
    María F Visintini Jaime, Flavia Redko, Liliana V Muschietti, Rodolfo H Campos, Virginia S Martino, Lucia V Cavallaro, In vitro antiviral activity of plant extracts from Asteraceae medicinal plants, Virology Journal, 2013, 10, 1, 245

    CrossRef

  14. 14
    Andrijana Meščić, Danijel Glavač, Amar Osmanović, Davorka Završnik, Mario Cetina, Damjan Makuc, Janez Plavec, Simon M. Ametamey, Silvana Raić-Malić, N-alkylated and O-alkylated regioisomers of 5-(hydroxyalkyl)pyrimidines: Synthesis and structural study, Journal of Molecular Structure, 2013, 1039, 160

    CrossRef

  15. 15
    Alberto Diez-Torrubia, Silvia Cabrera, Sonia de Castro, Carlos García-Aparicio, Gwenn Mulder, Ingrid De Meester, María-José Camarasa, Jan Balzarini, Sonsoles Velázquez, Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme, European Journal of Medicinal Chemistry, 2013, 70, 456

    CrossRef

  16. 16
    Swati Jain, Pardeep Kumar, Raj K. Vyas, Prabhat Pandit, Ajay K. Dalai, Occurrence and Removal of Antiviral Drugs in Environment: A Review, Water, Air, & Soil Pollution, 2013, 224, 2

    CrossRef

  17. 17
    Giovanna Bruni, Mariarosa Maietta, Lauretta Maggi, Piercarlo Mustarelli, Chiara Ferrara, Vittorio Berbenni, Chiara Milanese, Alessandro Girella, Amedeo Marini, Preparation and Physicochemical Characterization of Acyclovir Cocrystals with Improved Dissolution Properties, Journal of Pharmaceutical Sciences, 2013, 102, 11
  18. 18
    Selwyn J. Hurwitz, Raymond F. Schinazi, Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors, Current Opinion in HIV and AIDS, 2013, 8, 6, 556

    CrossRef

  19. You have free access to this content19
    Rafik Karaman, Prodrugs Design Based on Inter- and Intramolecular Chemical Processes, Chemical Biology & Drug Design, 2013, 82, 6
  20. 20
    Christina Bell, Michel Desjardins, Pierre Thibault, Kerstin Radtke, Proteomics Analysis of Herpes Simplex Virus Type 1-Infected Cells Reveals Dynamic Changes of Viral Protein Expression, Ubiquitylation, and Phosphorylation, Journal of Proteome Research, 2013, 12, 4, 1820

    CrossRef

  21. 21
    S.-y. N. Huang, J. Murai, I. Dalla Rosa, T. S. Dexheimer, A. Naumova, W. H. Gmeiner, Y. Pommier, TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs, Nucleic Acids Research, 2013, 41, 16, 7793

    CrossRef

  22. 22
    G. Andrei, R. Snoeck, Antiviral Agents, 2013,

    CrossRef

  23. 23
    Sharon B. Wigal, Amanda A. Wong, Angela Jun, Annamarie Stehli, Robin Steinberg-Epstein, Marc A. Lerner, Adverse Events in Medication Treatment-Naïve Children with Attention-Deficit/Hyperactivity Disorder: Results from a Small, Controlled Trial of Lisdexamfetamine Dimesylate, Journal of Child and Adolescent Psychopharmacology, 2012, 22, 2, 149

    CrossRef

  24. 24
    Li-Qiang Yan, Ning Li, Min-Hua Zong, First and facile enzymatic synthesis of β-fucosyl-containing disaccharide nucleosides through β-galactosidase-catalyzed regioselective glycosylation, Journal of Biotechnology, 2012, 164, 2, 371

    CrossRef

  25. 25
    Erik de Clercq, Milestones in the discovery of antiviral agents: nucleosides and nucleotides, Acta Pharmaceutica Sinica B, 2012, 2, 6, 535

    CrossRef

  26. 26
    Guillaume Sautrey, Igor Clarot, Ewa Rogalska, Jean-Bernard Regnouf-de-Vains, New potential prodrugs of aciclovir using calix[4]arene as a lipophilic carrier: synthesis and drug-release studies at the air–water interface, New Journal of Chemistry, 2012, 36, 10, 2060

    CrossRef

  27. 27
    Martín A. Palazzolo, María Pérez-Sánchez, Adolfo M. Iribarren, Elizabeth S. Lewkowicz, Pablo Domínguez de María, Organocatalytic synthesis of novel purine and pyrimidine acyclic nucleosides, Tetrahedron Letters, 2012, 53, 50, 6797

    CrossRef

  28. You have free access to this content28
    Rafik Karaman, Khuloud K. Dajani, Alaa Qtait, Mustafa Khamis, Prodrugs of Acyclovir – A Computational Approach, Chemical Biology & Drug Design, 2012, 79, 5
  29. 29
    Wen-Li Gao, Huan Liu, Ning Li, Min-Hua Zong, Regioselective enzymatic undecylenoylation of 8-chloroadenosine and its analogs with biomass-based 2-methyltetrahydrofuran as solvent, Bioresource Technology, 2012, 118, 82

    CrossRef

  30. 30
    Orrette R. Wauchope, Cameron Johnson, Pasupathy Krishnamoorthy, Graciela Andrei, Robert Snoeck, Jan Balzarini, Katherine L. Seley-Radtke, Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2′-deoxy nucleoside analogues, Bioorganic & Medicinal Chemistry, 2012, 20, 9, 3009

    CrossRef

  31. 31
    Rosa M. Suárez, Maria Paz Matía, José Luis Novella, Andres Molina, Antonio Cosme, Juan José Vaquero, Julio Alvarez-Builla, Synthesis of 9,9′-[1,2-Ethanediylbis(oxymethylene)]bis-2-amino-1,9-dihydro-6H-purin-6-one, an Impurity of Acyclovir, Molecules, 2012, 17, 12, 8735

    CrossRef

  32. 32
    Stephen K. Tyring, Stephanie Plunkett, Anita R. Scribner, Robert E. Broker, John N. Herrod, Lane T. Handke, John M. Wise, Paul A. Martin, Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: A randomized, double-blind, active-controlled trial, Journal of Medical Virology, 2012, 84, 8
  33. 33
    Anastasia L. Khandazhinskaya, Maxim V. Jasko, Inna L. Karpenko, Pavel N. Solyev, Natalia A. Golubeva, Marina K. Kukhanova, 5′-Phosphonate Derivatives of 2′,3′-Dideoxy-3′-Thiacytidine as New Anti-HIV Prodrugs, Chemical Biology & Drug Design, 2011, 78, 1
  34. 34
    Erik De Clercq, A 40-Year Journey in Search of Selective Antiviral Chemotherapy*, Annual Review of Pharmacology and Toxicology, 2011, 51, 1, 1

    CrossRef

  35. 35
    Adrian S. Ray, Karl Y. Hostetler, Application of kinase bypass strategies to nucleoside antivirals, Antiviral Research, 2011, 92, 2, 277

    CrossRef

  36. 36
    Graciela Andrei, Robert Snoeck, Emerging drugs for varicella-zoster virus infections, Expert Opinion on Emerging Drugs, 2011, 16, 3, 507

    CrossRef

  37. 37
    Min Ye, Chun-Yang Yu, Ning Li, Min-Hua Zong, Highly regioselective glucosylation of 2′-deoxynucleosides by using the crude β-glycosidase from bovine liver, Journal of Biotechnology, 2011, 155, 2, 203

    CrossRef

  38. 38
    Wen-Li Gao, Ning Li, Min-Hua Zong, Highly regioselective synthesis of undecylenic acid esters of purine nucleosides catalyzed by Candida antarctica lipase B, Biotechnology Letters, 2011, 33, 11, 2233

    CrossRef

  39. 39
    Rubén de Regil-Hernández, Fernando Martínez-Lagos, Amalia Rodríguez-Bayón, José-Vicente Sinisterra, New Green Synthesis and Formulations of Acyclovir Prodrugs, CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59, 9, 1089

    CrossRef

  40. 40
    Varsha Gandhi, Yet Another Nucleoside Analog for Pancreatic Cancer, Gastroenterology, 2011, 140, 2, 400

    CrossRef

  41. 41
    Every Molecule Tells a Story, 2011,

    CrossRef

  42. 42
    Anastasiya Khandazhinskaya, Elena Matyugina, Elena Shirokova, Anti-HIV therapy with AZT prodrugs: AZT phosphonate derivatives, current state and prospects, Expert Opinion on Drug Metabolism & Toxicology, 2010, 6, 6, 701

    CrossRef

  43. 43
    K. Chono, K. Katsumata, T. Kontani, M. Kobayashi, K. Sudo, T. Yokota, K. Konno, Y. Shimizu, H. Suzuki, ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2, Journal of Antimicrobial Chemotherapy, 2010, 65, 8, 1733

    CrossRef

  44. 44
    Ning Li, Thomas J. Smith, Min-Hua Zong, Biocatalytic transformation of nucleoside derivatives, Biotechnology Advances, 2010, 28, 3, 348

    CrossRef

  45. 45
    Caroline Smal, Didier Vertommen, Rachid Amsailale, Angélique Arts, Hervé Degand, Pierre Morsomme, Mark H. Rider, Eric Van Den Neste, Françoise Bontemps, Casein kinase 1δ activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity, Archives of Biochemistry and Biophysics, 2010, 502, 1, 44

    CrossRef

  46. 46
    Atsuko YAMASHITA, Membrane-Protein Crystallography and Potentiality for Drug Design-An Example from Neurotransmitter Transporter Homolog LeuT, Nihon Kessho Gakkaishi, 2010, 52, 1, 76

    CrossRef

  47. 47
    Mario Cetina, Janja Makarević, Afërdita Nura-Lama, Self-assembling of dihydroxypropyl 5,6-dihydrothymine derivatives, Journal of Molecular Structure, 2010, 980, 1-3, 156

    CrossRef

  48. 48
    Konstantinos E. Litinas, Andreas Thalassitis, Synthesis of fused dihydropyrido[e]purines via ring closing metathesis, Tetrahedron Letters, 2010, 51, 49, 6451

    CrossRef

  49. 49
    A. Paju, M. Päri, A. Selyutina, E. Žusinaite, A. Merits, T. Pehk, K. Siirde, A.-M. Müürisepp, T. Kailas, M. Lopp, Synthesis of Novel Acyclic Nucleoside Analogues with Anti-Retroviral Activity, Nucleosides, Nucleotides and Nucleic Acids, 2010, 29, 9, 707

    CrossRef

  50. 50
    Giorgio Brandi, Luigia Rossi, Giuditta F. Schiavano, Enrico Millo, Mauro Magnani, A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity, International Journal of Antimicrobial Agents, 2009, 34, 2, 177

    CrossRef

  51. 51
    Erik De Clercq, Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives, Medicinal Research Reviews, 2009, 29, 4
  52. 52
    Guillaume Castel, Noël Tordo, Nouvelles stratégies pour la conception de molécules antivirales, Revue Francophone des Laboratoires, 2009, 2009, 417, 91

    CrossRef

  53. 53
    Ning Li, Min-Hua Zong, Ding Ma, Regioselective acylation of nucleosides and their analogs catalyzed by Pseudomonas cepacia lipase: enzyme substrate recognition, Tetrahedron, 2009, 65, 5, 1063

    CrossRef

  54. 54
    Ning Li, Min-Hua Zong, Ding Ma, Thermomyces lanuginosus lipase-catalyzed regioselective acylation of nucleosides: Enzyme substrate recognition, Journal of Biotechnology, 2009, 140, 3-4, 250

    CrossRef

  55. 55
    Erik De Clercq, 2009,

    CrossRef

  56. 56
    Motoki Itahashi, Shiro Higaki, Daisuke Sugahara, Koji Sugioka, Tatsunori Deai, Kazumasa Takao, Kozaburo Hayashi, Yoshikazu Shimomura, A-5021, Cornea, 2008, 27, 3, 334

    CrossRef

  57. 57
    Rita Cortesi, Elisabetta Esposito, Acyclovir delivery systems, Expert Opinion on Drug Delivery, 2008, 5, 11, 1217

    CrossRef

  58. 58
    Satyendra Mishra, Krishanpal Karmodiya, Prasanna Parasuraman, Avadhesha Surolia, Namita Surolia, Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents, Bioorganic & Medicinal Chemistry, 2008, 16, 10, 5536

    CrossRef

  59. 59
    Fujun Li, Hans Maag, Tom Alfredson, Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting, Journal of Pharmaceutical Sciences, 2008, 97, 3
  60. 60
    Ning Li, Min-Hua Zong, Ding Ma, Regioselective Acylation of Nucleosides Catalyzed by Candida Antarctica Lipase B: Enzyme Substrate Recognition, European Journal of Organic Chemistry, 2008, 2008, 32
  61. 61
    Yi-jun Dao, Zheng Jiao, Ming-kang Zhong, Simultaneous determination of aciclovir, ganciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection, Journal of Chromatography B, 2008, 867, 2, 270

    CrossRef

  62. 62
    Rafał Gawin, Erik De Clercq, Lieve Naesens, Mariola Koszytkowska-Stawińska, Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure, Bioorganic & Medicinal Chemistry, 2008, 16, 18, 8379

    CrossRef

  63. 63
    Erik De Clercq, The discovery of antiviral agents: Ten different compounds, ten different stories, Medicinal Research Reviews, 2008, 28, 6
  64. 64
    Yazan Safadi, Valérie Vivet-Boudou, Roland Marquet, HIV-1 reverse transcriptase inhibitors, Applied Microbiology and Biotechnology, 2007, 75, 4, 723

    CrossRef

  65. 65
    Mariola Koszytkowska-Stawińska, Ewa Kołaczkowska, Ewa Adamkiewicz, Erik De Clercq, Synthesis and antiviral properties of aza-analogues of ganciclovir derived from 5,5-bis(hydroxymethyl)pyrrolidin-2-one, Tetrahedron, 2007, 63, 43, 10587

    CrossRef

  66. 66
    Mariola Koszytkowska-Stawińska, Katarzyna Kaleta, Wojciech Sas, Erik De Clercq, Synthesis and Antiviral Properties of Aza-Analogues ofAcyclovir, Nucleosides, Nucleotides and Nucleic Acids, 2007, 26, 1, 51

    CrossRef

  67. 67
    Shigemasa Sawada, Masami Takei, Hirotake Inomata, Takamasa Nozaki, Hidetaka Shiraiwa, What is after cytokine-blocking therapy, a novel therapeutic target — Synovial Epstein-Barr virus for rheumatoid arthritis, Autoimmunity Reviews, 2007, 6, 3, 126

    CrossRef

  68. 68
    Erik De Clercq, 2007,

    CrossRef

  69. 69
    Karen K. Biron, Antiviral drugs for cytomegalovirus diseases, Antiviral Research, 2006, 71, 2-3, 154

    CrossRef

  70. 70
    J. K. Aronson, Clinical Pharmacology: Past, Present, and Future, British Journal of Clinical Pharmacology, 2006, 61, 6
  71. 71
    Pedro Besada, Liaman K. Mamedova, Krishnan K. Palaniappan, Zhan-Guo Gao, Bhalchandra V. Joshi, Lak Shin Jeong, Mortimer M. Civan, Kenneth A. Jacobson, Nucleoside Prodrugs of A3 Adenosine Receptor Agonists and Antagonists, Collection of Czechoslovak Chemical Communications, 2006, 71, 6, 912

    CrossRef

  72. 72
    Cheng Chang, Sean Ekins, Praveen Bahadduri, Peter W. Swaan, Pharmacophore-based discovery of ligands for drug transporters, Advanced Drug Delivery Reviews, 2006, 58, 12-13, 1431

    CrossRef

  73. 73
    Mariola Koszytkowska-Stawińska, Wojciech Sas, Erik De Clercq, Synthesis of aza-analogues of Ganciclovir, Tetrahedron, 2006, 62, 44, 10325

    CrossRef

  74. 74
    James R. Beadle, Karl Y. Hostetler, Alkoxyalkyl Ester Prodrugs of Antiviral Nucleoside Phosphates and Phosphonates,
  75. 75
    Chemical Delivery Systems,
  76. 76
    Jose-Vicente Sinisterra, Andrés-Rafael Alcántara, Marcos Almendros, María J. Hernáiz, José-María Sánchez-Montero, Jorge Trelles, Enzyme-Catalyzed Synthesis of Nonnatural or Modified Nucleosides, Encyclopedia of Industrial Biotechnology,
  77. 77
    Laurence Le Cleach, Ludovic Trinquart, Benedicte Lebrun-Vignes, Bruno Giraudeau, Olivier Chosidow, Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients, The Cochrane Library,